NYSE:CBT - Cabot Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$45.26 -1.23 (-2.65 %)
(As of 01/23/2019 04:00 PM ET)
Previous Close$46.49
Today's Range$44.98 - $46.90
52-Week Range$39.57 - $68.63
Volume226,705 shs
Average Volume358,709 shs
Market Capitalization$2.72 billion
P/E Ratio11.23
Dividend Yield2.77%
Beta1.46
Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber. It also provides specialty grades of carbon black used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. Further, it provides cesium formate brines used as a drilling and completion fluid primarily in high pressure and high temperature oil and gas well construction; and fine cesium chemicals used in a range of industries and applications that include catalysts, doping agents, and brazing fluxes. The company sells its products primarily through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.

Receive CBT News and Ratings via Email

Sign-up to receive the latest news and ratings for CBT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous chemical products
Sub-IndustryCommodity Chemicals
SectorBasic Materials
CUSIP12705510
Phone617-345-0100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.24 billion
Cash Flow$7.6067 per share
Book Value$20.78 per share

Profitability

Net Income$-113,000,000.00

Miscellaneous

Employees4,600
Market Cap$2.72 billion
OptionableOptionable

Cabot (NYSE:CBT) Frequently Asked Questions

What is Cabot's stock symbol?

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

How often does Cabot pay dividends? What is the dividend yield for Cabot?

Cabot announced a quarterly dividend on Friday, January 11th. Investors of record on Friday, February 22nd will be paid a dividend of $0.33 per share on Friday, March 8th. This represents a $1.32 annualized dividend and a yield of 2.92%. The ex-dividend date of this dividend is Thursday, February 21st. View Cabot's Dividend History.

How will Cabot's stock buyback program work?

Cabot announced that its Board of Directors has initiated a stock buyback program on Monday, July 16th 2018, which permits the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 10.3% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's board of directors believes its stock is undervalued.

How were Cabot's earnings last quarter?

Cabot Corp (NYSE:CBT) posted its quarterly earnings data on Monday, November, 5th. The specialty chemicals company reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.09 by $0.09. The specialty chemicals company earned $850 million during the quarter, compared to analyst estimates of $856.76 million. Cabot had a negative net margin of 3.49% and a positive return on equity of 18.82%. The firm's revenue was up 17.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.91 EPS. View Cabot's Earnings History.

When is Cabot's next earnings date?

Cabot is scheduled to release their next quarterly earnings announcement on Monday, February 4th 2019. View Earnings Estimates for Cabot.

How can I listen to Cabot's earnings call?

Cabot will be holding an earnings conference call on Tuesday, February 5th at 2:00 PM Eastern. Interested parties can register for or listen to the call using this link.

What guidance has Cabot issued on next quarter's earnings?

Cabot issued an update on its FY19 earnings guidance on Monday, November, 5th. The company provided EPS guidance of $4.35-4.75 for the period, compared to the Thomson Reuters consensus estimate of $4.70. Cabot also updated its FY 2019 guidance to $4.35-4.75 EPS.

What price target have analysts set for CBT?

5 analysts have issued 12 month price targets for Cabot's shares. Their predictions range from $72.00 to $82.00. On average, they expect Cabot's stock price to reach $76.60 in the next year. This suggests a possible upside of 69.2% from the stock's current price. View Analyst Price Targets for Cabot.

What is the consensus analysts' recommendation for Cabot?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cabot.

Has Cabot been receiving favorable news coverage?

News articles about CBT stock have trended very positive recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cabot earned a coverage optimism score of 3.7 on InfoTrie's scale. They also gave news coverage about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days.

Who are some of Cabot's key competitors?

Who are Cabot's key executives?

Cabot's management team includes the folowing people:
  • Mr. Sean D. Keohane, Pres, CEO & Director (Age 52)
  • Mr. Brian A. Berube, Sr. VP & Gen. Counsel (Age 57)
  • Mr. Hobart C. Kalkstein, Sr. VP, Pres of Reinforcement Materials Segment & Pres of Americas Region (Age 49)
  • Mr. Patrick M. Prevost, Advisor & Director (Age 64)
  • Ms. Erica McLaughlin, Sr. VP & CFO (Age 43)

Who are Cabot's major shareholders?

Cabot's stock is owned by a number of of institutional and retail investors. Top institutional investors include Cabot Wellington LLC (0.54%), Peregrine Capital Management LLC (0.31%), Retirement Systems of Alabama (0.13%), Bank of Montreal Can (0.07%), Fox Run Management L.L.C. (0.03%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Cabot stock include Brian A Berube, Eduardo E Cordeiro, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Institutional Ownership Trends for Cabot.

Which institutional investors are selling Cabot stock?

CBT stock was sold by a variety of institutional investors in the last quarter, including Cabot Wellington LLC, BTIM Corp., Retirement Systems of Alabama, Bank of Montreal Can, Louisiana State Employees Retirement System, Oakbrook Investments LLC and Patten & Patten Inc. TN. Company insiders that have sold Cabot company stock in the last year include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Insider Buying and Selling for Cabot.

Which institutional investors are buying Cabot stock?

CBT stock was purchased by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Fox Run Management L.L.C., Ipswich Investment Management Co. Inc., IFP Advisors Inc and Meeder Asset Management Inc.. View Insider Buying and Selling for Cabot.

How do I buy shares of Cabot?

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cabot's stock price today?

One share of CBT stock can currently be purchased for approximately $45.26.

How big of a company is Cabot?

Cabot has a market capitalization of $2.72 billion and generates $3.24 billion in revenue each year. The specialty chemicals company earns $-113,000,000.00 in net income (profit) each year or $4.03 on an earnings per share basis. Cabot employs 4,600 workers across the globe.

What is Cabot's official website?

The official website for Cabot is http://www.cabot-corp.com.

How can I contact Cabot?

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected]


MarketBeat Community Rating for Cabot (NYSE CBT)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  312 (Vote Outperform)
Underperform Votes:  356 (Vote Underperform)
Total Votes:  668
MarketBeat's community ratings are surveys of what our community members think about Cabot and other stocks. Vote "Outperform" if you believe CBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel